0001209191-22-037111.txt : 20220615
0001209191-22-037111.hdr.sgml : 20220615
20220615191445
ACCESSION NUMBER: 0001209191-22-037111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220613
FILED AS OF DATE: 20220615
DATE AS OF CHANGE: 20220615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CROSS HERB
CENTRAL INDEX KEY: 0001230721
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38935
FILM NUMBER: 221019008
MAIL ADDRESS:
STREET 1: 3061 ZANKER RD
CITY: SAN JOSE
STATE: CA
ZIP: 95134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atreca, Inc.
CENTRAL INDEX KEY: 0001532346
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273723255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD,
STREET 2: SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-595-2595
MAIL ADDRESS:
STREET 1: 835 INDUSTRIAL ROAD,
STREET 2: SUITE 400
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-13
0
0001532346
Atreca, Inc.
BCEL
0001230721
CROSS HERB
C/O ATRECA, INC., 835 INDUSTRIAL RD.
SUITE 400
SAN CARLOS
CA
94070
0
1
0
0
Chief Financial Officer
Employee stock option (right to buy)
1.845
2022-06-13
4
A
0
95000
A
2031-01-26
Class A Common Stock
95000
95000
D
Employee stock option (right to buy)
13.97
2022-06-13
4
D
0
95000
0.00
D
2031-01-26
Class A Common Stock
95000
0
D
Employee stock option (right to buy)
1.845
2022-06-13
4
A
0
224999
A
2029-04-04
Class A Common Stock
224999
224999
D
Employee stock o16.74ption (right to buy)
12.06
2022-06-13
4
D
0
224999
0.00
D
2029-04-04
Class A Common Stock
224999
0
D
Employee stock option (right to buy)
1.845
2022-06-13
4
A
0
97000
A
2030-02-25
Class A Common Stock
97000
97000
D
Employee stock option (right to buy)
22.07
2022-06-13
4
D
0
97000
0.00
D
2030-02-25
Class A Common Stock
97000
0
D
1/48 of the Option vests in equal monthly installments as measured from 1/1/2021. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
The transactions reported herein reflect a one-time stock option repricing effective on June 13, 2022 (the "Option Repricing"). The Option Repricing applies to options with exercise prices greater than or equal to $9.00 per share held by all employees of the Issuer as of June 13, 2022. Pursuant to the Option Repricing, the exercise price of the repriced options, including the Option, has been amended to reduce the exercise price to $1.845 per share, the closing price of the Issuer's Class A common stock on the Nasdaq Global Select Market as of the date of the Option Repricing. There have been no other changes to the terms of the repriced options, including the Option. The Option Repricing does not apply to options held by non-employee directors of the Issuer.
1/4 of the Option vests on 2/25/2020 and 1/48 of the Option vests in equal monthly installments as measured from 2/25/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
2/48 of the Option vests on 3/1/2020 and 1/48 of the Option vests in equal monthly installments as measured from 3/1/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time.
/s/ Herbert Cross
2022-06-15